Replay available

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call

MacroGenics, Inc. (NASDAQ: MGNX) Q4 2024 earnings conference call, held 2025-03-20. Replay captured from the company's public earnings webcast.

Thu, March 20, 2025 at 4:30 PMendedReplay
MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call

Hosted by

Featured presenters

Dr. Scott Koenig

President and Chief Executive Officer, Macrogenics

Dr. Steven Eck

Senior Vice President, Clinical Development and Chief Medical Officer, Macrogenics

Peter Lawson

Analyst, Barclays

Jonathan Chang

Analyst, Learing Partners

Unknown Analyst

Analyst (name not provided)

John Miller

Analyst, Evercore

Stephen Whaley

Analyst, Stifel

Sylvain Churkin

Analyst, Citizens

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Macrogenics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.076 President and Chief Financial Officer of Microgenics. 00:00:04.076 -- 00:00:06.337 Please proceed. 00:00:06.980 -- 00:00:10.665 Thank you, Operator. Good afternoon and welcome to Microgenics Conference Call to discuss 00:00:10.665 -- 00:00:15.752 our fourth quarter and full year 2024 financial and operational results. 00:00:15.752 -- 00:00:20.178 For anyone who has not had the chance to review the results, we've issued a press release 00:00:20.178 -- 00:00:23.462 this afternoon outlining today's announcements. 00:00:23.462 -- 00:00:28.094 This release is available under the Investors tab on our website at macrogenics.com. 00:00:28.094 -- 00:00:32.358 You may also listen to this conference call via webcast on our website, where it will 00:00:32.358 -- 00:00:37.263 be archived for 30 days beginning approximately two hours after the call is completed. 00:00:37.263 -- 00:00:41.007 I'd like to alert listeners that today's discussion will include statements about the 00:00:41.007 -- 00:00:46.012 company's future expectations, plans, and prospects that constitute forelooking statements 00:00:46.012 -- 00:00:50.857 for purposes of a safe harbor provision under the Private Securities Litigation Reform 00:00:50.857 -- 00:00:52.779 Act of 1995. 00:00:52.779 -- 00:00:57.237 Actual results may differ materially from those indicated by these forelooking statements. 00:00:57.237 -- 00:01:00.160 as a result of various important factors, 00:01:00.160 -- 00:01:04.325 including those discussed in the risk factor section of our annual, quarterly, and current 00:01:04.325 -- 00:01:07.308 reports filed with the SEC. 00:01:07.308 -- 00:01:11.272 In addition, any forward-looking statements represent our views only as of today and 00:01:11.272 -- 00:01:15....